Global Traumatic Brain Injury Assessment & Management Devices Market Research Report 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Traumatic Brain Injury Assessment & Management Devices Market Size, Share & Trends Analysis Report by Device (Imaging Devices, Monitoring Devices), by Technique, by End-use, by Region, and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering.

The global traumatic brain injury assessment and management devices market size is anticipated to reach USD 5.5 billion by 2028 and is expected to expand at a CAGR of 8.3% from 2021 to 2028

Increasing incidence of traumatic brain injuries (TBIs) and rising awareness about TBIs are driving the market.

Traumatic brain injuries are a serious public health concern and every year, it contributes a significant number of cases globally. Falls are one of the leading causes of hospitalization among TBI patients, followed by motor vehicle accidents.

According to the CDC, presently 3.5 million people are living with permanent TBI-related disability in the U.S. Thus, increasing incidence of TBIs due to mounting cases of road accidents and injuries is expected to fuel the demand for TBIs assessment and management devices.

Moreover, the COVID-19 pandemic has in20creased the demand for TBIs assessment and management devices. As per the research study published in the NCBI report 2020, certain patients hospitalized for coronavirus infection showed clinical and neurochemical signs of brain injury. This is expected to boost the market growth.

Furthermore, the incorporation of the latest technologies and the introduction of new products by market players are likely to boost the market growth during the forecast period. For instance, NanoDx System launched by BioDirection Company is a rapid point-of-care (POC) test that precisely confirms concussion/TBI in less than 2 minutes.

Traumatic Brain Injury Assessment And Management Devices Market Report Highlights

• On the basis of device, the imaging devices segment dominated the overall market with a share of 54.04% in 2020 as these devices are widely used in identifying patients with TBIs
• Based on technique, the intracranial pressure (ICP) monitoring segment dominated the overall market with a share of 54.61% in 2020. This method is considered to be a gold standard for the accurate measurement of ICP in patients with severe brain injury
• By end-use, hospitals dominated the market with a share of 43.17% in 2020 as brain surgeries are one of the most complicated procedures that are reliant on high quality and advanced equipment, which are available in hospitals
• North America dominated the market with a revenue share of 52.73% in 2020 owing to the presence of well-established healthcare facilities and availability of the latest treatment procedures

Traumatic Brain Injuries (TBIs) Assessment and Management Devices Market Variables, Trends & Scope

Market Driver Analysis

• Growing incidence of Traumatic Brain Injuries (TBIs) due to increasing sports injuries and road accidents
• Increasing demand for non-invasive devices for the assessment TBI
• Rising awareness about TBI

Market Restraints Analysis

• Issues related to product approval and commercialization
• Shortage of trained professionals in the under-developed economies to perform neurosurgery

Market Lineage Outlook

• Parent Market Outlook
• Ancillary Market Outlook

Penetration & Growth Prospect Mapping

Post-operative Treatment Therapy Insights

List Of Regulations, By Country

Product Pipeline Analysis

Consumer behavior analysis

• Trends & Preferences
• Factors Affecting Buying
• Product Adoption

Major Deals and Strategic Alliances

• Geographical Expansion
• Product Launches

Traumatic Brain Injuries (TBIs) Assessment and Management Devices: Market Analysis Tools

• Industry Analysis – Porter’s
• SWOT Analysis, By PEST

Companies Mentioned

• Compumedics Limited
• Nihon Kohden Corporation
• BioDirection, Inc.
• BrainScope, Inc.
• Neural Analytics, Inc.
• Advanced Brain Monitoring, Inc.
• Oculogica
• InfraScan, Inc.
• Integra Lifesciences Corporation
• Raumedic AG

For more information about this report visit https://www.researchandmarkets.com/r/lbudv2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900